GlassScriptPhysician profile
Branislav Cizmar
NPI 1679554372
$7,897.18
in general payments reported to CMS, 2019-2025
44 companies · $1,163 in 2025
The $1,163 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,454 · 2020: $346 · 2021: $548 · 2022: $495 · 2023: $2,117 · 2024: $775 · 2025: $1,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,230 · Food and Beverage: $1,824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,230.23 |
| Food and Beverage | $1,823.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,113.73 | 2019-2023 | Da Vinci Surgical System |
| Applied Medical Resources Corporation | $1,502.51 | 2023 | Gelpoint V-Path |
| Coloplast Corp | $1,076.00 | 2024-2025 | |
| Abbvie INC. | $583.31 | 2019-2024 | |
| Pfizer INC. | $239.28 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $236.27 | 2021-2025 | |
| Coopersurgical, INC. | $175.31 | 2019-2025 | Mara Console, Paragard T 380a, Ally II Ups |
| Aspira Women'S Health INC | $144.04 | 2019-2024 | Ova1 |
| Boston Scientific Corporation | $143.32 | 2023-2025 | Solyx Sis System, Axonics, Bulkamid |
| Organon LLC | $136.65 | 2022-2023 | Nexplanon |
| Astellas Pharma US INC | $112.44 | 2019-2024 | Veozah |
| Welch Allyn | $108.45 | 2021 | |
| Myovant Sciences INC. | $106.42 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $91.15 | 2019-2021 | |
| Caldera Medical, INC | $70.77 | 2023 | Desara |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $69.17 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $64.94 | 2021-2025 | Aptima |
| Therapeuticsmd, INC. | $63.46 | 2019-2022 | |
| Lupin INC. | $63.45 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.62 | 2019-2022 | |
| Axonics, INC. | $52.36 | 2022-2024 | Axonics |
| Conmed Corporation | $47.70 | 2019 | |
| Shield Therapeutics INC | $45.86 | 2025 | |
| Minerva Surgical, INC | $45.33 | 2019-2024 | |
| Roche Diagnostics Corporation | $45.15 | 2019-2020 | |
| Ascend Therapeutics US, LLC | $44.37 | 2023 | |
| Channel Medsystems, INC. | $42.89 | 2022 | |
| Evofem Biosciences, INC. | $42.08 | 2025 | Phexxi, Solosec, Phexx |
| Ethicon US, LLC | $38.86 | 2019-2023 | Dermabond Prineo, Stratafix, Surgicel Nu-Knit |
| Allergan, INC. | $35.63 | 2019 | |
| Avanos Medical | $32.18 | 2019 | |
| Davol INC. | $30.62 | 2025 | Arista |
| Dysis Medical, INC. | $27.00 | 2019 | |
| Biom'Up Sa | $24.13 | 2019 | |
| Viiv Healthcare Company | $23.46 | 2020 | |
| Baxter Healthcare | $22.49 | 2020 | |
| Exeltis, USA INC. | $22.43 | 2020 | |
| Becton, Dickinson and Company | $21.42 | 2023 | Bd Onclarity |
| Meditrina | $17.85 | 2024 | |
| Medicem INC. | $17.23 | 2021 | |
| Sumitomo Pharma America, INC. | $15.59 | 2023 | Myfembree |
| Zyla Life Sciences, INC. | $15.54 | 2020 | |
| Kci USA, INC. | $13.92 | 2023 | Ranger |
| Avion Pharmaceuticals | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Branislav Cizmar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.